Local Prescribing Information (Rheumatology):

 

Tocilizumab Injection IV and SC [Actemra®] -  Actemra IV PI v13.0 dt. Feb 2021 CiplaActemra IV PI v13.0 dt. Feb 2021 Roche | Actemra SC PI v7.0 dt. Mar 2022 CiplaActemra SC PI v7.0 dt. Mar 2022 Roche


Rituximab Injection [Ristova® and Ikgdar®] -  Ristova PI v12.0 dt. Jan 2021Ikgdar PI v12.0 dt. Jan 2021

 

 

 

 

Safety Update Information for Healthcare Professionals (Rheumatoid Arthritis):

 

Actemra® (Tocilizumab): A new Important Identified Risk: Hepatotoxicity

 

Disclaimer - Kindly note that it takes approximately up to 6 months to implement the revised PI in commercial stocks imported into India after submission to the health authorities. All PIs notified to or approved by the CDSCO are published on this website for all the HCPs prescribing Roche drugs within 10 calendar days.